Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STABLE-HYPONATOREMIA: DDAVP for severe hyponatremia correction
jRCTs041220117Recruiting
- Start
- Jan 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised trial of desmopressin in hyponatraemia (2 arms). Primary endpoint: Maximum delta serum sodium level at 24 hours. Started Jan 2023; status: recruiting.
02
Drugs
desmopressin
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on jRCTs041220117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041220117.